Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling? (vol 26, pg 211, 2023)

被引：0

|

作者：

Chen, Ethan

Ling, Alexander L.

Reardon, David A.

Chiocca, E. Antonio

机构：

来源：

NEURO-ONCOLOGY | 2024年 / 26卷 / 04期

关键词：

D O I：

10.1093/neuonc/noad241

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：779 / 779

页数：1

相关论文

共 50 条

[21] It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials (vol 192, pg 393, 2010)
Denham, J. W.
MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (11) : 655 - 655
[22] How Electric Vehicles and the Grid Work Together: Lessons Learned from One of the Largest Electric Vehicle Trials in the World (Reprinted from IEEE Power and Energy Magazine, vol 16, pg 64-76, 2018)
Quiros-Tortos, J.
Ochoa, L.
Butler, T.
IEEE POWER & ENERGY MAGAZINE, 2023, 21 (02):
[23] Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials (vol 108, pg 196, 2020)
Chen, Dawei
Verma, Vivek
Patel, Roshal R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 623 - 623
[24] Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (vol 36, pg 2910, 2019)
Glassberg, Marilyn K.
Nathan, Steven D.
Lin, Chin-Yu
Morgenthien, Elizabeth A.
Stauffer, John L.
Chou, Willis
Noble, Paul W.
ADVANCES IN THERAPY, 2019, 36 (10) : 2927 - 2929
[25] Two-phase active contour method for semiautomatic segmentation of the heart and blood vessels from MRI images for 3D visualization (vol 26, pg 9, 2002)
Makowski, P
Sorensen, TS
Therkildsen, SV
Materka, A
Stodkilde-Jorgensen, H
Pedersen, EM
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2003, 27 (06) : 535 - 535
[26] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (vol 29, pg 2835, 2023)
Kirkwood, John M.
Del Vecchio, Michele
Weber, Jeffrey
Hoeller, Christoph
Grob, Jean-Jacques
Mohr, Peter
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Mackiewicz, Jacek
Rutkowski, Piotr
Arenberger, Petr
Quereux, Gaelle
Meniawy, Tarek M.
Ascierto, Paolo A.
Menzies, Alexander M.
Durani, Piyush
Lobo, Maurice
Campigotto, Federico
Gastman, Brian
Long, Georgina V.
NATURE MEDICINE, 2024, 30 (03) : 906 - 906
[27] HAWK and HARRIER Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration (vol 1, pg 89, 2021)
Dugel, P. U.
OPHTHALMOLOGY, 2022, 129 (05) : 593 - 596
[28] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)
Allinson, James Peter
Chaturvedi, Nishi
Wong, Andrew
LANCET, 2023, 402 (10418): : 2196 - 2196
[29] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)
Verstovsek, S.
Gerds, A. T.
Vannucchi, A. M.
LANCET, 2023, 401 (10386): : 1426 - 1426
[30] Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (vol 21, pg 125, 2022)
Mignot, E.
Mayleben, D.
Fietze, I
LANCET NEUROLOGY, 2022, 21 (06): : E6 - E6

← 1 2 3 4 5 →